Expert Review of Clinical Pharmacology

Top Research Topics at Expert Review of Clinical Pharmacology?

The journal investigates studies in Internal medicine, Pharmacology, Intensive care medicine, Clinical trial and Drug. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Gastroenterology, Endocrinology, Oncology and Cardiology. Oncology research presented in it encompasses a variety of subjects, including Cancer and Chemotherapy.

Research on Pharmacology presented in Expert Review of Clinical Pharmacology focuses, in particular, on Pharmacokinetics and Pharmacodynamics. In the journal, Adverse effect, Immunology, Pharmacotherapy, Disease and Dosing are investigated in conjunction with one another to address concerns in Intensive care medicine research.

• Internal medicine (26.60%)
• Pharmacology (23.07%)
• Intensive care medicine (21.71%)

What are the most cited papers published in the journal?

• Polypharmacology: drug discovery for the future. (257 citations)
• Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. (221 citations)
• Corticosteroids in brain cancer patients: benefits and pitfalls (165 citations)

Research areas of the most cited articles at Expert Review of Clinical Pharmacology:

The journal publications are organized to reinforce research efforts on Pharmacology, Intensive care medicine, Internal medicine, Drug and Clinical trial. The journal papers facilitate discussions on Pharmacology that incorporate concepts from other fields like Receptor, Rheumatoid arthritis and Bioinformatics. The most cited publications explore research in Oncology and overlapping concepts in Breast cancer to expand the discourse in Internal medicine.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

The foci of the journal are Internal medicine, Intensive care medicine, Clinical trial, Oncology and Adverse effect. Expert Review of Clinical Pharmacology focuses on Internal medicine but the discussions also offer insight into other areas such as Endocrinology and Cardiology. Intensive care medicine research featured in the journal incorporates concerns from various other topics such as 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Dosing.

It is focused mainly on Coronavirus disease 2019 (COVID-19), particularly Pandemic. Expert Review of Clinical Pharmacology focused on Clinical trial research but expanded to cover Combination therapy. Expert Review of Clinical Pharmacology facilitates discussions on Oncology that incorporate concepts from other fields like Chemotherapy and Immunotherapy.

The most cited articles from the last journal are:

• Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. (16 citations)
• Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature. (7 citations)
• Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Expert Review of Clinical Pharmacology (based on the number of publications) are:

• Brian Godman (13 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Sherifa A. Hamed (11 papers) absent at the last edition,
• Ritu Singh (10 papers) absent at the last edition,
• Awadhesh Kumar Singh (10 papers) absent at the last edition,
• Catherine M.T. Sherwin (8 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Review of Clinical Pharmacology (based on the number of publications) are:

• Boston Children's Hospital (24 papers) published 4 papers at the last edition the same number as at the previous edition,
• University of Milan (19 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• Sapienza University of Rome (16 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Thomas Jefferson University (13 papers) absent at the last edition,
• Seconda Università degli Studi di Napoli (13 papers) published 3 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.77% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.33% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.83% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 13.33% of all publications and 62.50% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Contributors Profile

Determining the profile of regular contributors to the Expert Review of Clinical Pharmacology can provide insight into the backgrounds and expertise of authors who significantly influence the journal's contents. We can assess authors by a brief analysis of their academic qualifications, their affiliations or associated institutions, and their areas of interest or specialization. For instance, we may find that a significant percentage of authors who contribute regularly are accomplished researchers or academics in the field of Internal Medicine, with a number of them possessing advanced qualifications such as PhDs, or MPharm. They may be affiliated to notable educational or research institutions. Some might be recognized as experts in specific fields of study that are often covered in the journal, such as Gastroenterology, Endocrinology, Oncology and Cardiology. In-depth information on authors’ qualification, expertise, and professional status would significantly add value to the journal, demonstrating its capacity to attract and publish papers from authorities in the field. This in turn can serve as an indication of the journal's credibility and relevance in the academic and professional circles of Clinical Pharmacology. For context on academic qualifications, the typical training for a nurse practitioner, who might apply the findings of the Clinical Pharmacology research published in this journal, can be understood by looking at some of the best np programs in Tennessee.